Sarah is a Principal Biostatistician at the Cancer Research UK Clinical Trials Unit (CRCTU). She joined the CRCTU in 2006 with a focus on breast and urological cancers. Her trial focus in mainly phase III solid tumour cancers thought she is involved in the design, supervision, analysis and reporting of clinical trials in a variety of clinical areas. Her research focus is in methodology for de-escalation trials and reporting of harms data.
Sarah is statistical lead on several trials within CRCTU and sits on external Data Monitoring Committees for trials run at other trials units.